Exponent, Inc. (NASDAQ:EXPO) is included among the 15 Overlooked Dividend Stocks to Buy Right Now.
On November 2, Truist lowered its price target for Exponent, Inc. from $100 to $90 while maintaining a Buy rating, according to a report by The Fly. The analyst noted that artificial intelligence could create new opportunities for the company as clients seek its expertise in failure analysis. However, there is also a risk that increased efficiencies from automation could reduce billable hours, and the consulting sector may continue to face pressure from such technological changes.
In its third-quarter report, Exponent, Inc. highlighted strong performance, with double-digit net revenue growth driven by the strength of its diversified portfolio. Growth was particularly strong in dispute-related work across the energy, transportation, life sciences, and construction sectors. As AI becomes more integrated into safety-critical systems, the company is supporting clients in managing risks and innovating responsibly.
For Q3 2025, total revenue rose 8% to $147.1 million, while revenue before reimbursements increased 10% to $137.1 million, up from $136.3 million and $125.1 million, respectively, in the same period last year.
Exponent, Inc. is a global engineering and scientific consulting firm that delivers multidisciplinary solutions for complex technical and scientific problems.
READ NEXT: 15 Best Dividend Growth Stocks to Buy Now and 15 Best DRIP Stocks to Own Right Now.
